Rachman Ilya M 4
4 · Immix Biopharma, Inc. · Filed Jul 18, 2022
Insider Transaction Report
Form 4
Rachman Ilya M
DirectorCEO and Chairman
Transactions
- Award
Stock Options
2022-07-14+250,000→ 520,000 totalExercise: $2.64Exp: 2032-07-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Options vest monthly in equal amounts over 48 months.